ATAI Life Sciences (ATAI) Stock Highlights

1.24 | -3.13%

2024-09-19 05:17:32

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Statistics

Range Today

1.23 1.29

Volume Today 425.4K

Range 1 Year

1.02 2.85

Volume 1 Year 265.09M

Range 3 Year

1.02 17.81

Volume 3 Year 742.72M

Range 10 Year

1.02 22.91

Volume 10 Year 776.43M

Highlights

Market Capitalization 218.14M (small)

Floating Shares 128.63M

Current Price 1.24

Price To Earnings -3.44

Price To Revenue 403.09

Price To Book 1.3

Earnings Per Share -0.36

Payout Ratio 0%

Performance

Latest -3.13%

1 Month 0%

3 Months -6.77%

6 Months -30.73%

1 Year -15.07%

3 Years -92.13%

5 Years -94.1%

10 Years -94.1%

Benchmarks

Market Capitalization

191 / 368

Gross Profits

142 / 278

Total Revenue

260 / 300

Total Rank

294 / 368

Free Cashflow

192 / 352

Performance 5 years

322 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.